Last10K.com

Bristol Myers Squibb Co (BMY) SEC Filing 8-K Material Event for the period ending Tuesday, October 8, 2019

Bristol Myers Squibb Co

HISTORY TOOLS
CIK: 14272 Ticker: BMY

View differences made from one to another to evaluate Bristol Myers Squibb Co's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Bristol Myers Squibb Co.

Continue

Assess how Bristol Myers Squibb Co's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Bristol Myers Squibb Co's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Financial Statements, Disclosures and Schedules

Inside this 8-K Corporate News

Document And Entity Information

Material Contracts, Statements, Certifications & more

Bristol Myers Squibb Co provided additional information to their SEC Filing as exhibits

Exhibit 99.1: Press Release Of Bristol-Myers Squibb Company
Ticker: BMY
CIK: 14272
Form Type: 8-K Corporate News
Accession Number: 0001140361-19-018099
Submitted to the SEC: Tue Oct 08 2019 8:00:39 AM EST
Accepted by the SEC: Tue Oct 08 2019
Period: Tuesday, October 8, 2019
Industry: Pharmaceutical Preparations
Events:
  1. Financial Exhibit
  2. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/bmy/0001140361-19-018099.htm